呼气末闭塞动作诱导的颈动脉多普勒变化能否预测脓毒性休克患者的液体反应性
本研究为前瞻性单中心研究,纳入18例无心律失常的机械通气脓毒性休克成人患者,共进行44次测量,在基线、20秒呼气末闭塞测试(EEOt)期间及500 mL液体负荷后记录颈动脉多普勒峰值流速(CDPV)、校正流时间(cFT)与EV1000™脉搏轮廓分析的血流动力学变量。液体反应性定义为液体负荷后心脏指数(CI)增加≥15%,本研究中液体反应率为43.2%。EEOt期间CI增加≥5.35%预测液体反应性的敏感性78.9%、特异性91.7%、AUROC 0.85;CDPV增加≥10.5%预测液体反应性的特异性96.2%、敏感性53.0%、AUROC 0.74;61%的CDPV测量(从-13.5到9.5 cm/s)落在灰区;cFT变化不能准确预测液体反应性。作者认为,在无心律失常的脓毒性休克患者中,20秒EEOt期间CDPV增加>10.5%以>95%的特异性预测液体反应性,颈动脉多普勒联合EEOt可能有助于在无法进行有创血流动力学监测时优化前负荷,但61%的灰区是主要局限。
要点
- 在无心律失常的脓毒性休克机械通气患者中,20秒EEOt期间CDPV增加≥10.5%预测液体反应性,特异性96.2%、敏感性53.0%、AUROC 0.74。
- EEOt期间CI增加≥5.35%预测液体反应性,敏感性78.9%、特异性91.7%、AUROC 0.85。
- EEOt期间CDPV变化与CI变化显著相关(r=0.51 [0.26-0.71]),cFT变化相关性较低(r=0.35 [0.1-0.58])。
- cFT变化不能准确预测液体反应性;61%的CDPV测量(从-13.5到9.5 cm/s)落在灰区,是该方法的主要局限。
- 作者认为,颈动脉多普勒联合EEOt可能有助于在无法进行有创血流动力学监测时优化前负荷。
适用人群与场景
- 成人、血流动力学不稳定、机械通气、脓毒性休克且无心律失常的患者。
诊断标准与关键阈值
- 液体反应性定义为500 mL液体负荷后心脏指数(CI)增加≥15%。
- EEOt期间CI增加≥5.35%为预测液体反应性的阈值。
- EEOt期间CDPV增加≥10.5%为预测液体反应性的阈值。
处置流程与药物剂量
- 在基线、20秒呼气末闭塞测试(EEOt)期间及500 mL液体负荷后,用颈动脉多普勒记录CDPV和cFT,并用EV1000™脉搏轮廓分析记录血流动力学变量。
研究设计与关键结果
- 前瞻性单中心研究,18例机械通气脓毒性休克无心律失常患者,共44次测量,液体反应率43.2%。
- EEOt期间CDPV变化与CI变化显著相关(r=0.51 [0.26-0.71]);cFT变化与CI变化相关性较低(r=0.35 [0.1-0.58])。
- EEOt期间CI增加≥5.35%预测液体反应性:敏感性78.9%、特异性91.7%、AUROC 0.85。
- EEOt期间CDPV增加≥10.5%预测液体反应性:特异性96.2%、敏感性53.0%、AUROC 0.74。
- 61%的CDPV测量(从-13.5到9.5 cm/s)落在灰区。
- EEOt期间cFT变化不能准确预测液体反应性。
证据类型、等级与局限
- 证据类型:前瞻性单中心研究。
- 局限:61%的CDPV测量落在灰区是主要局限;研究为回顾性注册(Clinicaltrials.gov NCT04470856,2020年7月14日)。
对床旁实践的改变
- 作者认为,在无心律失常的脓毒性休克机械通气患者中,20秒EEOt期间CDPV增加>10.5%以>95%的特异性预测液体反应性,颈动脉多普勒联合EEOt可能有助于在无法进行有创血流动力学监测时优化前负荷。
- 61%的CDPV测量落在灰区,是该预测方法的主要局限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: An increase in cardiac index (CI) during an end-expiratory occlusion test (EEOt) predicts fluid responsiveness in ventilated patients. However, if CI monitoring is unavailable or the echocardiographic window is difficult, using the carotid Doppler (CD) could be a feasible alternative to track CI changes. This study investigates whether changes in CD peak velocity (CDPV) and corrected flow time (cFT) during an EEOt were correlated with CI changes and if CDPV and cFT changes predicted fluid responsiveness in patients with septic shock.
METHODS: Prospective, single-center study in adults with hemodynamic instability. The CDPV and cFT on carotid artery Doppler and hemodynamic variables from the pulse contour analysis EV1000™ were recorded at baseline, during a 20-s EEOt, and after fluid challenge (500 mL). We defined responders as those who increased CI ≥ 15% after a fluid challenge.
RESULTS: We performed 44 measurements in 18 mechanically ventilated patients with septic shock and without arrhythmias. The fluid responsiveness rate was 43.2%. The changes in CDPV were significantly correlated with changes in CI during EEOt (r = 0.51 [0.26-0.71]). A significant, albeit lower correlation, was found for cFT (r = 0.35 [0.1-0.58]). An increase in CI ≥ 5.35% during EEOt predicted fluid responsiveness with 78.9% sensitivity and 91.7% specificity, with an area under the ROC curve (AUROC) of 0.85. An increase in CDPV ≥ 10.5% during an EEOt predicted fluid responsiveness with 96.2% specificity and 53.0% sensitivity with an AUROC of 0.74. Sixty-one percent of CDPV measurements (from - 13.5 to 9.5 cm/s) fell within the gray zone. The cFT changes during EEOt did not accurately predict fluid responsiveness.
CONCLUSIONS: In septic shock patients without arrhythmias, an increase in CDPV greater than 10.5% during a 20-s EEOt predicted fluid responsiveness with > 95% specificity. Carotid Doppler combined with EEOt may help optimize preload when invasive hemodynamic monitoring is unavailable. However, the 61% gray zone is a major limitation (retrospectively registered on Clinicaltrials.gov NCT04470856 on July 14, 2020).
参考来源
- D'Arrigo S, Dell'Anna AM, Sandroni C, et al. Can carotid artery Doppler variations induced by the end-expiratory occlusion maneuver predict fluid responsiveness in septic shock patients? Crit Care. 2023. PMID: 37076861. doi:10.1186/s13054-023-04422-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。